Gesynta Pharma

Lediga tjänster

Clinical Trial Manager

We are recruiting a Clinical Trial Manager. In this position, you will lead and oversee clinical trials from Phase 1 to 3 in pain and inflammation, with a focus on Women’s Health and endometriosis. This is an exceptional opportunity to join a small, highly skilled team and play a key role in advancing new therapeutic options for patients worldwide.

About Gesynta 

Gesynta is a clinical-stage pharmaceutical company dedicated to developing innovative treatments targeting mPGES-1, a critical pro-inflammatory enzyme involved in conditions such as endometriosis. Founded on research from Karolinska Institutet in Sweden, Gesynta is at the forefront of advancing health solutions in areas of high unmet medical needs. The company's leading compound, vipoglanstat, is currently in Phase 2 where it is evaluated as a non-hormonal, non-opioid treatment alternative with potential for disease-modification in endometriosis.

With a strong pipeline and backing from prominent investors, Gesynta is poised to make significant advancements in the field of chronic inflammatory disorders such as endometriosis. For further details about the groundbreaking work, please visit www.gesynta.se.

About the Role

In this role, you will work with the study team and oversee the planning, execution and reporting of clinical studies. You will be instrumental in managing day-to-day operations, timelines, budgets and risk management while fostering collaboration with internal stakeholders and external partners, including Contract Research Organizations (CROs).

Key responsibilities:

  • Oversee operational management of Phase 1-3 clinical studies in pain and inflammation
  • Serve as primary contact for CROs and external partners for the allocated studies
  • Ensure compliance with applicable regulations (FDA, EMA, ICH, GCP), and SOPs
  • Be part of CRO/vendor selection and oversight
About You

To be considered for this role you need the following qualifications:

  • Academic degree in Life Sciences, such as Biomedicine, Pharmacy, Medicine, Biotechnology, or equivalent
  • At least 5 years' experience in clinical trial management (CTM, CPM, CSM or similar), preferably including Phase 1-3 studies, ideally in a multi-country setting
  • Documented training in ICH-E6 (R3) GCP
  • Solid experience in vendor management and CRO oversight
Additional desirable skills:
  • Proven ability to collaborate and lead cross-functional teams to meet daily deliverables with high quality
  • Experience from interaction with regulatory authorities (EMA, FDA, etc.)
  • Project leadership, including effective communication, managing budgets and timelines
  • Proficiency in document management, eTMF/CTMS systems
  • Experience with studies in endometriosis (gynecology)

Preferred location: Stockholm area.

What to Expect

Gesynta is a rapidly growing company built on Nobel Prize-winning research and solid financial backing. In this innovative, entrepreneurial environment, you’ll have significant responsibility and can make a real impact, working closely with highly experienced colleagues. You will be offered a permanent position with competitive salary and benefits.  This is your chance to join a mission-driven team, transforming healthcare with a focus on Women’s Health and beyond.

How to Apply

All applications are processed by BRAVE Recruitment Sweden via the “Apply” link. Applications cannot be processed via email or other channels.

Please note that applicants must already have valid authorization to work in Sweden and be able to work on-site in the Stockholm area without employer-provided visa sponsorship or relocation support.

We encourage you to apply soon, as interviews are conducted on an ongoing basis. For any questions about this role, please contact Eva Rämme Bremberg at BRAVE Recruitment Sweden at +46 70 750 75 70.

Applications are being reviewed continuously, and early submission is recommended.

LinkedIn

Läs mer om Gesynta Pharma

Gesynta Pharma bygger sin forskning på banbrytande forskning från Karolinska Institutet.

Medlemmarna i vår ledningsgrupp och styrelse har omfattande erfarenhet av utveckling och kommersialisering av läkemedel.

Endometrios är en kronisk, inflammatorisk, östrogenberoende sjukdom som drabbar miljoner kvinnor över hela världen.

Vipoglanstat, vår läkemedelskandidat för endometrios, befinner sig i fas 2. GS-073 är redo för klinisk fas 1 för kronisk inflammatorisk smärta.